The McAlpine lab and the Swirski lab (@SwirskiLab) are looking to hire a technician to support lab operations, experiments, and colony management. If you would like to be part of a dynamic and collaborative team at the @SinaiHeartBlood please reach out!
More comprehensive analysis of the developing pediatric and adult human gut at the single cell level-Slim pickings for you enteroendocrine fans @Nature https://t.co/rNDeOh6AHu
Immune networks within the glial cell ecosystem maintain brain health.
Our latest is out today in @nature. Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease.
This was a wonderful collaboration with @RudyTanzi and his team. 1/
https://t.co/Bl1nPkk9MA
The McAlpine lab is officially open, and we are hiring! If you are interested in immune function, sleep, cardiovascular disease, or Alzheimer’s disease, and want to live in beautiful NYC please get in touch! @SinaiHeartBlood@SinaiBrain Please RT. https://t.co/gDrrhKKGdA
Very exciting progress on getting the mAb to fight against SARS-CoV-2: Potent human neutralizing antibodies elicited by SARS-CoV-2 infection | bioRxiv https://t.co/fMwnwYdH6l
🏦 Financing: the average cost of development of a diagnostic is 20-100 M. Given the low reimbursement rates for diagnostics compared to therapeutics, the appetite for funding is low in the US. Asian VC communities are much more open to fund new technologies and it shows !
Let’s play a little game.
Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after.
Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?